Showing results (151-160 of 320) with videos related to

Sort By:
Pageof 32
Cancer Research|August 1, 1982
Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinomaI E Smith, A L Harris, M Morgan, et al.
British Journal of Cancer|July 1, 1985
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patientsM Dowsett, S J Santner, R J Santen, et al.
Cancer Research|December 1, 1980
Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamideB M Bryant, M Jarman, M H Baker, et al.
British Journal of Cancer|July 1, 1978
Growth of human tumour cell colonies from biopsies using two soft-agar techniquesV D Courtenay, P J Selby, I E Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?H Bonnefoi, S Diebold-Berger, P Therasse, et al.
British Journal of Cancer|July 1, 1977
Hodgkin's disease in childrenI E Smith, M J Peckham, T J McElwain, et al.
Current Pharmaceutical Design|November 25, 2005
Bioplex technology: novel synthetic gene delivery pharmaceutical based on peptides anchored to nucleic acidsOscar E Simonson, Mathias G Svahn, Elisabeth Törnquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancerE Fokkema, H J Groen, J Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancerD W Miles, I E Smith, R E Coleman, et al.
Anti-Cancer Drugs|November 26, 1999
Results of an independent oncology review board of pivotal clinical trials of gemcitabine in non-small cell lung cancerS J Gwyther, M S Aapro, S R Hatty, et al.
Pageof 32